In this free webinar, learn how modeling the tumor microenvironment in vitro supports next-generation cancer research and drug discovery. Attendees will understand the limitations of traditional tumor models and why new in vitro systems are needed. The featured speakers will discuss how co-culturing tumoroids, CAFs and immune cells replicates the tumor microenvironment and has the potential to revolutionize cancer research.
TORONTO, Nov. 10, 2025 /PRNewswire/ — A deeper understanding of the tumor microenvironment (TME) is vital for advancing cancer research and developing therapies. Traditional tumor models remain limited by interspecies differences, variable reproducibility and their inability to replicate the dynamic, multicellular environment of tumors fully. This webinar will explore emerging strategies to address these limitations by introducing a novel co-culture approach that more accurately replicates the tumor microenvironment in vitro.
Tumoroids are derived from patient tumors and maintain the underlying genetic and histological features of the original tissue. They represent a significant advance for personalized oncology and drug testing. However, tumoroid models lack critical stromal and immune components of the TME, limiting their ability to reproduce the cell–cell and cell–matrix interactions that influence tumor progression and treatment response.
In this webinar, the featured speakers will discuss different tumor modeling strategies and share an innovative method that involves co-culturing tumoroids with cancer-associated fibroblasts (CAFs) and immune cells to reconstruct the cellular complexity of the tumor microenvironment in vitro. They will further explain how this new approach brings researchers closer to a true “patient in a dish” for cancer research and next-generation drug development.
Register for this webinar to learn how modeling the tumor microenvironment in vitro supports next-generation cancer research and drug discovery.
Join experts from Discovery Life Sciences, Shawn Fahl, VP Lab Operations, Cell Services & R&D, Biospecimens; and Meredith Osborn, Associate Director Product Management, for the live webinar on Wednesday, December 3, 2025, at 1:30pm EST (10:30am PST).
For more information, or to register for this event, visit Rebuilding the Tumor Microenvironment for In Vitro Discovery.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit www.xtalks.com
For information about hosting a webinar visit www.xtalks.com/why-host-a-webinar/
Contact:
Vera Kovacevic
Tel: +1 (416) 977-6555 x371
Email: vkovacevic@xtalks.com
SOURCE Xtalks
TGA approval enables regional launch of Owlet’s clinically validated, award-winning infant health monitor; Owlet360™ subscription…
Concludes Distribution Agreement with Gore® for VIABIL® in the United States and Canada, Effective January…
WESTMINSTER, Colo.--(BUSINESS WIRE)--TriSalus Life Sciences, Inc. (Nasdaq: TLSI) (“TriSalus” or the “Company”), an oncology company…
BOSTON, Dec. 05, 2025 (GLOBE NEWSWIRE) -- A recent setback due to unexpected safety concern…
—Long-term Phase 1/2a and open label extension (OLE) data for zorevunersen on top of standard…
Monthly reductions in seizure frequency of 90.9% among participants treated for ≥48 months in the…